Immix Biopharma, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:IMMX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 22.95 M19.89 M15.64 M20.08 M104.84 M95.82 M 총 부채 9.7 M10.3 M10.98 M11.82 M11.04 M11.45 M 자본금 총액 13.25 M9.59 M4.65 M8.26 M93.8 M84.36 M 총 부채 및 주주자본 22.95 M19.89 M15.64 M20.08 M104.84 M95.82 M 총부채 —————— 순부채 ——————

뉴스

Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High?

시티즌스, Immix Biopharma에 대해 ’아웃퍼폼’ 등급으로 투자 분석 개시

Citizens initiates Immix Biopharma stock coverage with outperform rating

Immix Biopharma, FDA 혁신 치료제 지정 후 주가 상승

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Immix Biopharma CFO, 주식 5천 달러 상당 매수

Immix Biopharma (IMMX) CEO, 주식 4975달러 매수

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares